Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Source Tissue

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)

Search term: breast cancer cell

<< < Results 101 - 200 of 309 > >>
download as CSV
download all results as CSV
EC Number Recommended Name Source Tissue Commentary Reference
Show all pathways known for 2.4.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.3uridine phosphorylase breast cancer cell negative correlation between UPase expression and the clinical outcome of breast cancer 673810
Show all pathways known for 2.4.2.30Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.30NAD+ ADP-ribosyltransferase breast cancer cell - 736899
Show all pathways known for 2.4.2.4Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.4thymidine phosphorylase breast cancer cell - 684460, 684466, 686140, 688302, 705495
Display the reaction diagram Show all sequences 2.4.3.8alpha-N-acetylneuraminate alpha-2,8-sialyltransferase breast cancer cell - 736910
Display the reaction diagram Show all sequences 2.4.3.8alpha-N-acetylneuraminate alpha-2,8-sialyltransferase breast cancer cell tissue samples of primary invasive breast cancer cases 699089
Display the reaction diagram Show all sequences 2.4.3.9lactosylceramide alpha-2,3-sialyltransferase breast cancer cell - 702982
Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.60protein geranylgeranyltransferase type II breast cancer cell - 658377
Show all pathways known for 2.6.1.42Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.42branched-chain-amino-acid transaminase breast cancer cell - 758728
Show all pathways known for 2.6.1.42Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.42branched-chain-amino-acid transaminase breast cancer cell BCATc and BCATm are increased in breast cancer 758657
Show all pathways known for 2.6.1.52Display the reaction diagram Show all sequences 2.6.1.52phosphoserine transaminase breast cancer cell immunohistochemical detection, in breast carcinoma PSAT1 expression is significantly associated with poor grade tumors and local relapse 760151
Show all pathways known for 2.6.1.52Display the reaction diagram Show all sequences 2.6.1.52phosphoserine transaminase breast cancer cell transcriptional regulators TAZ/YAP activity positively correlates with transaminase expression in breast cancer patients 759123
Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.64glutamine-phenylpyruvate transaminase breast cancer cell transcriptional regulators TAZ/YAP activity positively correlates with transaminase expression in breast cancer patients 759123
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1056-phosphofructo-2-kinase breast cancer cell - 737973, 760902, 761915
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.107diacylglycerol kinase (ATP) breast cancer cell - 761306
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.127inositol-trisphosphate 3-kinase breast cancer cell - 760540
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.137phosphatidylinositol 3-kinase breast cancer cell - 707976
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.137phosphatidylinositol 3-kinase breast cancer cell ER-positive breast cancer cells (UMB-1Ca) are grown as tumors in ovariectomized athymic nude mice 686138
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.138ceramide kinase breast cancer cell - 761664
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.138ceramide kinase breast cancer cell CERK expression is associated with an increased risk of recurrence in women with breast cancer 737976
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.138ceramide kinase breast cancer cell tissue samples of primary invasive breast cancer cases 699089
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.153phosphatidylinositol-4,5-bisphosphate 3-kinase breast cancer cell - 707977, 710406
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.154phosphatidylinositol-4-phosphate 3-kinase breast cancer cell isozyme PI3K-C2beta is overexpressed in human breast cancer cell lines 739216
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.183glycoprotein-mannosyl O6-kinase breast cancer cell - 762066
Show all pathways known for 2.7.1.32Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.32choline kinase breast cancer cell - 671362, 672898, 723311, 759595, 760183
Show all pathways known for 2.7.1.48Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.48uridine/cytidine kinase breast cancer cell analysis of the correlation between UCK2 gene expression and breast cancer survival, overview 759533
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.671-phosphatidylinositol 4-kinase breast cancer cell non-specific infiltrating duct and infiltrating lobular carcinomas 721967
Show all pathways known for 2.7.1.74Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.74deoxycytidine kinase breast cancer cell - 761315
Show all pathways known for 2.7.1.91Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.91sphingosine kinase breast cancer cell - 671356
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.94acylglycerol kinase breast cancer cell enzyme overexpression 739046
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell - 490103, 672895, 690303, 690447, 701713
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell EphA2 forms a complex with ErbB2, resulting in enhanced activation of Ras-MAPK signaling and RhoA GTPase 693355
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell overexpression of EGFR-TK 662724
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell overexpression of Her2-receptor 661551
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell overexpression of Ron 690303
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell - 490442, 490457, 490469, 661457, 662172, 662174, 676266, 691526
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell breast cancer 490443
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell breast carcinomas 490594
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell breast tumours 490596
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell PYK2 673223
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.10IkappaB kinase breast cancer cell - 676886
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.12cGMP-dependent protein kinase breast cancer cell - 721503, 723796
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.13protein kinase C breast cancer cell shows higher levels of PKCalpha than normal breast tissue 695064
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.16G-protein-coupled receptor kinase breast cancer cell - 761893
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.17Ca2+/calmodulin-dependent protein kinase breast cancer cell - 664865
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.17Ca2+/calmodulin-dependent protein kinase breast cancer cell differential expression of CaM-KI and CaM-KII in cell lines MCF-7 and MCF-10A 664506
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.18myosin-light-chain kinase breast cancer cell - 685933, 709713
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.20elongation factor 2 kinase breast cancer cell - 721661, 741080, 760810, 761029, 761285
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.22cyclin-dependent kinase breast cancer cell - 491470, 665497, 681873, 723656
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.24mitogen-activated protein kinase breast cancer cell - 665638
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.25mitogen-activated protein kinase kinase kinase breast cancer cell high expression level of MEKK3 665600
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.2mitogen-activated protein kinase kinase breast cancer cell impaired expression of MKK4 682214
Show all pathways known for 2.7.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.7.2.3phosphoglycerate kinase breast cancer cell moderate PGK1 expression 682792
Show all pathways known for 2.7.4.14Display the word mapDisplay the reaction diagram Show all sequences 2.7.4.14UMP/CMP kinase breast cancer cell distribution of the enzyme expression in different cancer tissue samples, overview 739700
Show all pathways known for 2.7.7.14Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.14ethanolamine-phosphate cytidylyltransferase breast cancer cell - 693518, 721513
Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.19polynucleotide adenylyltransferase breast cancer cell - 760831, 762420
Show all pathways known for 2.7.7.43Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.43N-acylneuraminate cytidylyltransferase breast cancer cell - 762081
Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.49RNA-directed DNA polymerase breast cancer cell - 692248
Display the reaction diagram Show all sequences 2.7.7.96ADP-D-ribose pyrophosphorylase breast cancer cell - 761999, 762060
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.29[heparan sulfate]-glucosamine 3-sulfotransferase 2 breast cancer cell - 662996, 761128
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.30[heparan sulfate]-glucosamine 3-sulfotransferase 3 breast cancer cell - 739207
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.30[heparan sulfate]-glucosamine 3-sulfotransferase 3 breast cancer cell 3-OST3A is epigenetically repressed in all breast cancer cell lines of a panel representative of distinct molecular subgroups, except in human epidermal growth factor receptor 2-positive (HER2+) sloan-kettering breast cancer (SKBR3) cells. Epigenetic mechanisms involved both DNA methylation and histone modifications, producing different repressive chromatin environments depending on the cell molecular signature 762063
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.4estrone sulfotransferase breast cancer cell - 671361, 676931, 691170, 691624, 693848, 701710, 701711, 761874
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.4estrone sulfotransferase breast cancer cell invasive, postmenopausal women 674994
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.4estrone sulfotransferase breast cancer cell preinvasive and invasive cancer cells 674994
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.4estrone sulfotransferase breast cancer cell reduced SULT1E1 expression in MCF-7 cells, but elevated SULT1E1 expression in breast tumour tissue, which also exhibits elevated E2 concentrations and increased Nrf2 expression as compared to the surrounding. Nrf2 is an oxidative stress responsive transcription protein, in situ expression analysis, overview 761875
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.B6[heparan sulfate]-iuronate 2-sulfotransferase breast cancer cell - 761128
Display the word mapDisplay the reaction diagram Show all sequences 3.1.26.5ribonuclease P breast cancer cell - 691597
Show all pathways known for 3.1.3.11Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.11fructose-bisphosphatase breast cancer cell - 690771
Show all pathways known for 3.1.3.11Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.11fructose-bisphosphatase breast cancer cell FBP1 is commonly upregulated in tumor tissues compared with non-tumor tissues regardless of histological type 750008
Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.16protein-serine/threonine phosphatase breast cancer cell elevated levels of PP5 protein occur in human breast cancer and suggest that PP5 over-expression may aid tumor progression 691077
Show all pathways known for 3.1.3.2Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.2acid phosphatase breast cancer cell - 679089
Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.48protein-tyrosine-phosphatase breast cancer cell - 749498
Show all pathways known for 3.1.3.5Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.55'-nucleotidase breast cancer cell - 682217, 691078, 693298, 750845
Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.66phosphatidylinositol-3,4-bisphosphate 4-phosphatase breast cancer cell primary, the enzyme is expressed in nonproliferative estrogen receptor-positive cells in the normal breast, and in estrogen receptor-positive, but not negative, breast cancer cell lines 716766
Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.86phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase breast cancer cell - 750315, 751180
Display the word mapDisplay the reaction diagram Show all sequences 3.1.31.1micrococcal nuclease breast cancer cell high SND1 enzyme expression level 729981
Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.2glycerophosphocholine phosphodiesterase breast cancer cell - 749764
Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.39alkylglycerophosphoethanolamine phosphodiesterase breast cancer cell - 696397, 703104, 728853
Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.39alkylglycerophosphoethanolamine phosphodiesterase breast cancer cell overexpression of the enzyme is frequently observed in cancer tissues, such as breast cancer and glioblastoma 728853
Show all pathways known for 3.1.4.46Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.46glycerophosphodiester phosphodiesterase breast cancer cell the isozyme GDPD5 is significantly overexpressed in highly malignant estrogen receptor negative compared to weakly malignant estrogen receptor positive human breast cancer cells and breast tumors from patients, GDPD5 expression in tumors and correlation to choline containing metabolite levels, overview 730482
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.1arylsulfatase (type I) breast cancer cell enzyme expression is unaltered in cancer tissue compared to nonmalignant tissue 707966
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.2steryl-sulfatase breast cancer cell - 682219, 706776
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.2steryl-sulfatase breast cancer cell expression of STS mRNA and STS activity are increased in malignant breast tissues compared with that in non-malignant tissues 656640
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.2steryl-sulfatase breast cancer cell hormone-dependent 714821
Display the reaction diagram Show all sequences 3.2.1.1271,6-alpha-L-fucosidase breast cancer cell - 699825
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.166heparanase breast cancer cell - 693933, 731867, 732087
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.166heparanase breast cancer cell express high levels of endogenous heparanase-1 693320
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.35hyaluronoglucosaminidase breast cancer cell - 703231
Show all pathways known for 3.2.1.51Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.51alpha-L-fucosidase breast cancer cell - 699825
Display the word mapDisplay the reaction diagram Show all sequences 3.3.2.11cholesterol-5,6-oxide hydrolase breast cancer cell enzyme ChEH is upregulated 752861
Display the word mapDisplay the reaction diagram Show all sequences 3.4.11.1leucyl aminopeptidase breast cancer cell immunohistochemistry analysis of expression levels of LAP3 in breast cancer tissues. Expression of LAP3 in 105 cases of breast cancer is analyzed. The expression rate of LAP3 differs in various pathological histological grades, phenotypes, overview 754242
Display the word mapDisplay the reaction diagram Show all sequences 3.4.11.3cystinyl aminopeptidase breast cancer cell N-methyl nitrosourea (NMU)-induced breast cancer 753943
Display the word mapDisplay the reaction diagram Show all sequences 3.4.11.9Xaa-Pro aminopeptidase breast cancer cell - 752870
Display the word mapDisplay the reaction diagram Show all sequences 3.4.13.9Xaa-Pro dipeptidase breast cancer cell - 700612
Display the word mapDisplay the reaction diagram Show all sequences 3.4.13.9Xaa-Pro dipeptidase breast cancer cell breast cancer tissue shows high enzyme activity, reduced collagen content and decreased expression of beta1-integrins 683557
Display the word mapDisplay the reaction diagram Show all sequences 3.4.13.9Xaa-Pro dipeptidase breast cancer cell increased prolidase activity in breast cancer tissue 707010
Display the word mapDisplay the reaction diagram Show all sequences 3.4.14.9tripeptidyl-peptidase I breast cancer cell - 678513
Display the word mapDisplay the reaction diagram Show all sequences 3.4.18.1cathepsin X breast cancer cell - 710431
Display the word mapDisplay the reaction diagram Show all sequences 3.4.19.12ubiquitinyl hydrolase 1 breast cancer cell present in cancerous cells originating from tissues that do not normally express UCH-L1, including pancreatic cancer, colorectal cancer and invasive breast cancer 752715
Display the word mapDisplay the reaction diagram Show all sequences 3.4.19.12ubiquitinyl hydrolase 1 breast cancer cell UCH-L3 mRNA level is significantly upregulated and UHCL1 mRNA level also show a non-significant increase in breast cancer tissue compared to adjacent normal breast tissue. Both UCH-L1 and UCH-L3 mRNA levels are significantly higher in high histological grade tumors than in low histological grade tumors. UCH-L1 mRNA level in tumors is approximately 10 times higher than that of UCH-L3 679040
<< < Results 101 - 200 of 309 > >>
download as CSV
download all results as CSV